Workflow
贴牌代工
icon
Search documents
ESG正在惩罚那些贴牌代工的企业
3 6 Ke· 2026-01-08 13:08
Core Viewpoint - The article discusses the significant issues surrounding the brand management and supply chain practices of Tong Ren Tang, highlighting the lack of accountability and transparency in the OEM (Original Equipment Manufacturer) model, which has led to consumer deception and quality crises [2][8][9]. Group 1: Brand Management Issues - A recent investigation revealed that a product marketed as "99% pure Antarctic krill oil" from Tong Ren Tang contained no actual krill oil, indicating severe product misrepresentation [2][4]. - The brand's authorization to a distributor, Sichuan Health Pharmaceutical, expired in March 2021, yet products under the Tong Ren Tang name continued to be sold online, exposing significant flaws in brand authorization management [4][6]. - The relationship between the involved companies is complex, with Sichuan Health Pharmaceutical being partially owned by Tong Ren Tang Health, raising questions about internal oversight and accountability [7]. Group 2: Supply Chain Accountability - The OEM model has led to a "responsibility void," where manufacturers deny knowledge of product quality issues, and brand owners refuse to take responsibility, resulting in a lack of consumer trust [8][9]. - This situation reflects a broader trend in Chinese enterprises, where supply chain ESG (Environmental, Social, and Governance) management is often neglected, leading to potential risks and consumer rights violations [9][20]. Group 3: ESG Transformation - The article emphasizes the need for a shift from traditional OEM practices to a more collaborative and sustainable supply chain model, where brands and manufacturers work together towards shared ESG goals [10][15]. - Companies like Starbucks and Nike are highlighted as examples of brands that are actively engaging in sustainable practices within their supply chains, setting new standards for accountability and environmental responsibility [10][12]. - The upcoming regulatory changes in 2025 will enforce stricter ESG compliance for companies, marking a significant shift in how businesses must approach supply chain management and sustainability [17][19][20].
贴牌代工的“爷爷的农场”,携57.3%高毛利闯港股
Guo Ji Jin Rong Bao· 2026-01-08 07:44
Core Viewpoint - The company "爷爷的农场" (Grandpa's Farm) is preparing for an IPO on the Hong Kong Stock Exchange, with a focus on the baby food market, where it ranks second in China with a GMV of 1.5 billion yuan and a market share of approximately 3.3% [2]. Group 1: Company Overview - "爷爷的农场" was established in 2015 and launched its first baby food product in 2018, expanding into the family food sector in 2021, creating two main business segments [3]. - The baby food segment is the primary revenue driver, generating 627 million yuan in the first nine months of 2025, accounting for over 80% of total revenue [3]. - The family food segment includes liquid milk, convenience foods, rice products, and seasonings, contributing 153 million yuan, or 19.6% of total revenue in the same period [3]. Group 2: Market Position and Competition - The company faces competition from the leading brand "英氏控股" (Ying's Holdings), which has a GMV of 2.6 billion yuan and a market share of 5.7% [2]. - The company has established a distribution network that includes 12 well-known maternal and infant retail chains and over 2,000 key retail outlets, reaching more than 10,000 terminal stores through 342 distributors [3]. Group 3: Industry Challenges - The company anticipates a decline in the number of children aged 0-6 years, projected to drop to approximately 60.9 million by 2029, with a compound annual growth rate of -5.5%, which may impact potential consumer numbers and revenue [3]. - The brand has faced controversy regarding its "foreign brand" image, as it was initially marketed as a Dutch brand, but is primarily operated by a Chinese company [4][5]. Group 4: Production and Quality Control - The company relies heavily on OEM manufacturing, with 62 suppliers, of which only 13 are overseas partners, raising concerns about quality control [6]. - The company has faced multiple product quality issues, including instances of non-compliance with safety standards, which could undermine consumer trust [10][12]. Group 5: Financial Performance - The company reported revenues of 622 million yuan in 2023 and 875 million yuan in 2024, with a year-on-year growth of 40.6% [13]. - The gross margin for the company reached 57.3% in the first nine months of 2025, comparable to leading brands in the food and beverage industry [14]. - Marketing expenses have increased significantly, accounting for over 36% of revenue, while R&D spending remains low, leading to declining net profit margins [15][16].
同仁堂,金字招牌在“贴牌”
Zhong Guo Xin Wen Wang· 2025-12-23 12:25
Core Viewpoint - The article discusses the potential risks and implications of the brand expansion strategy employed by Beijing Tongrentang, a well-known traditional Chinese medicine brand, highlighting issues related to product quality and brand integrity due to extensive licensing and outsourcing practices [1][3][10]. Group 1: Brand Integrity and Quality Issues - Beijing Tongrentang issued an apology regarding a product quality issue with its "99% high-purity Antarctic krill oil," which claimed a phospholipid content of 43% but was found to be 0% in actual tests [3][10]. - The brand's licensing model has led to a proliferation of products under the Tongrentang name, many of which are produced by third-party manufacturers, raising concerns about the authenticity and quality of these products [3][4][10]. - The complexity of brand ownership and licensing has resulted in confusion among consumers, as multiple entities within the Tongrentang group produce and sell products under similar names, leading to difficulties in distinguishing genuine products from counterfeit ones [6][7][10]. Group 2: Business Model and Market Strategy - The company has expanded its product offerings significantly, including health supplements and daily necessities, which has been referred to as the "Tongrentang Universe," but this expansion raises questions about brand dilution [3][4][10]. - Beijing Tongrentang Health Pharmaceutical has adopted a direct sales model for its health products, which is often associated with negative perceptions in the market, potentially risking the brand's reputation [10][12]. - The company is facing financial challenges, with a reported net profit of 1.526 billion yuan for 2024, marking an 8.54% decline year-on-year, indicating a need for strategic reevaluation amidst its aggressive expansion efforts [12]. Group 3: Consumer Trust and Brand Management - The article emphasizes the importance of establishing modern corporate governance and a robust authorization system to restore consumer trust in the Tongrentang brand, which has been built over a century [12]. - The dual approach of maintaining traditional practices while attempting to attract younger consumers through innovative strategies reflects the internal contradictions faced by the brand during its rapid expansion [12].
乐歌股份(300729) - 300729乐歌股份投资者关系管理信息20251024
2025-10-24 07:24
Group 1: Overseas Warehouse Operations - The gross margin of the overseas warehouse business remained stable in Q3, with an average utilization rate exceeding 70% [2] - The company has established 19 self-operated overseas warehouses covering a total area of 650,000 square meters as of September 2025, with revenue from this segment continuing to grow significantly [4] - The company served 1,932 outbound enterprises in the first three quarters, with shipment volume increasing by over 100% year-on-year [4] Group 2: Impact of Tariffs and Market Trends - The ongoing uncertainty in the China-U.S. trade environment has led to varying impacts on different consumer categories, particularly affecting optional consumer goods and offline supermarket products [3] - Despite challenges, the cross-border e-commerce sector remains robust, with core categories like smart standing desks showing steady growth [3] - The company anticipates a recovery in demand for its OEM business as the industry stabilizes post-tariff adjustments [4] Group 3: E-commerce Performance - Independent site sales accounted for over 40% of total cross-border e-commerce revenue, growing approximately 12% year-on-year [5] - The independent site channel demonstrates strong customer loyalty, with higher repurchase rates and average transaction values compared to platform-based channels [5] - The company aims to enhance brand differentiation and product innovation to maintain market share while focusing on profit quality in a competitive landscape [5]
网友购买阿迪达斯羽绒服,却发现竟是雪中飞代工,怎样看这一现象?
Xin Lang Cai Jing· 2025-10-22 02:24
Core Viewpoint - The recent revelation that a consumer's expensive Adidas down jacket was actually produced by a local OEM has sparked discussions about brand value and consumer awareness in the context of modern commercial practices [2][4]. Group 1: OEM Phenomenon - The phenomenon of OEM (Original Equipment Manufacturer) is not new, as consumers have long been aware of the existence of cheaper alternatives produced by OEMs for well-known brands [3][6]. - The practice of OEM is widespread across various industries, not just in clothing, and is considered a core model of modern commerce [3][4]. - Notable OEM manufacturers, such as Shenzhou International, have been recognized for producing garments for major global brands like Nike, Uniqlo, and Adidas since around 2005 [3]. Group 2: Brand Premium Logic - The advantages of the OEM model include economies of scale and specialization, allowing brands to focus on design and marketing while manufacturers handle production, thus reducing costs and increasing efficiency [4]. - Consumers often pay a premium for brands not necessarily for product quality but for trust and identity associated with the brand [4]. Group 3: Consumer Choices - Consumers have become more discerning, often opting for lower-priced alternatives from OEMs instead of paying high prices for branded products [6]. - The trend of "tag peeling," where consumers check the origin of products to avoid being misled, has become common, reflecting a shift towards more rational purchasing decisions [6]. - Ultimately, the decision to pay a brand premium depends on individual preferences, with some valuing brand prestige while others prioritize cost-effectiveness [6].
【聚焦IPO】同富股份再战IPO:近九成收入靠贴牌,毛利率低于同行,应收账款高企
Sou Hu Cai Jing· 2025-07-10 09:24
Core Viewpoint - Tongfu Co., Ltd. is attempting to go public on the Beijing Stock Exchange after three years of effort, focusing on its cross-border B2B e-commerce business, particularly in stainless steel insulated containers, which constitutes a significant portion of its revenue [2][8]. Group 1: Business Model and Revenue - The company heavily relies on OEM (Original Equipment Manufacturer) products, with OEM sales accounting for approximately 90% of its total revenue [8][10]. - Revenue is projected to grow from 1.973 billion yuan in 2022 to 2.760 billion yuan in 2024, reflecting a growth rate of 30.35%, primarily driven by increased sales of stainless steel containers [10][12]. - The company has diversified its product offerings, including plastic and glass containers, but the majority of its revenue still comes from stainless steel products, which account for 85.15% of total revenue [10]. Group 2: Financial Performance - The total assets of the company increased from approximately 1.365 billion yuan in 2022 to about 2.037 billion yuan in 2024, while shareholder equity rose from 812.93 million yuan to 1.177 billion yuan during the same period [11]. - The gross profit margin has declined from 25.86% in 2022 to 24.74% in 2024, which is below the industry average of 28.84% to 30.69% [13]. - Accounts receivable increased significantly, from 3.086 billion yuan in 2022 to 4.477 billion yuan in 2024, raising concerns about the company's credit policies and cash flow management [14][15]. Group 3: Strategic Challenges - The company exhibits a significant imbalance in its operational strategy, focusing more on marketing than on research and development, with R&D expenses constituting only 1.55% of revenue in 2024 [16][18]. - The reliance on external manufacturers for production is high, with about 65% of stainless steel containers produced by third parties, limiting the company's control over production quality and timelines [19]. - The company faces challenges in its path to IPO due to past legal issues involving its controlling shareholder, which may impact investor confidence [20]. Group 4: Market Dependency and Risks - Over 80% of the company's revenue comes from international sales, with significant exposure to the Americas and Europe, which accounted for over 74% of total sales [22][23]. - The company's heavy reliance on international markets poses risks related to trade policies, tariffs, and currency fluctuations, which could adversely affect profitability and growth [22][24]. - The transition from an OEM-focused model to a more self-sufficient production and branding strategy is crucial for the company's long-term sustainability and competitive advantage [24].
巴兰仕闯关北交所:外销贴牌贡献超七成营收
Jing Ji Guan Cha Bao· 2025-05-19 14:28
Core Viewpoint - Shanghai Balanshi Automotive Testing Equipment Co., Ltd. is currently in the inquiry stage of its IPO review, focusing on automotive repair and testing equipment, with a significant reliance on OEM sales for its revenue [1][2] Group 1: Company Overview - Balanshi specializes in the research and production of automotive maintenance, testing, and repair equipment, including tire changers, balancers, lifts, and refrigerant recovery machines [1] - The company submitted its IPO application to the Beijing Stock Exchange in September 2024, aiming to raise 300 million yuan for smart transformation and expansion projects [1] Group 2: Sales and Revenue Structure - The company’s overseas sales are primarily based on OEM, with OEM sales accounting for 89.05% and 90.14% of overseas sales revenue in 2020 and 2021, respectively [1] - From 2021 to the first half of 2024, overseas sales contributed 74.42% to 75.91% of the main business revenue, with OEM sales making up over 90% of overseas sales [1] - In the first half of 2024, Balanshi's overseas revenue was 379 million yuan, with approximately 341 million yuan coming from OEM sales, indicating that OEM contributions exceeded 70% of total revenue [1] Group 3: Risks and Challenges - The company faces significant risks due to its heavy reliance on the OEM model, which limits brand premium and bargaining power [2] - Potential risks include changes in foreign sales policies, supply chain stability issues, and delays in brand development [2] - The current geopolitical fluctuations and intensified industry competition create uncertainty regarding the company's ability to break through brand limitations and optimize market structure [2]